CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Exit or restructuring costs · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes EVP, President US gave up 3,011 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and CFO gave up 3,011 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 3,127 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale SVP and CFO sold 120,000 shares at $5.25 ($630,240)
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 3,011 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and CFO gave up 3,011 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 3,127 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 3,803 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 10,604 shares (to pay taxes)
Page 18 of 77 · 1,527 filings